SPONSORED
By Elric Langton | 9 January 2023
I have a financial interest in Poolbeg Pharma.
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a leading infectious disease-focused biopharmaceutical company, the share price was given a boost by 11% to 8.10p bid in early trading on the back of positive initial data analysis for its lead product POLB 001,Β a viral straiβ¦